Advertisement


Pedro T. Ramirez, MD, on Hysterectomy for Early Cervical Cancer: New Findings on Open vs Minimally Invasive Surgery

SGO 2022 Annual Meeting on Women’s Cancer

Advertisement

Pedro T. Ramirez, MD, of The University of Texas MD Anderson Cancer Center, discusses the final analysis of the LACC trial (Laparoscopic Approach to Cervical Cancer), which showed that women with early cervical cancer who need a radical hysterectomy may have worse outcomes with minimally invasive surgery compared with open surgery. All treatment guidelines support open surgery, which yields similar outcomes in terms of complications and quality of life (Abstract LBA10).



Related Videos

Gynecologic Cancers

Ursula A. Matulonis, MD, on Ovarian Cancer: New Data on Mirvetuximab Soravtansine

Ursula A. Matulonis, MD, of Dana-Farber Cancer Institute, discusses findings from the SORAYA study on the efficacy and safety of mirvetuximab soravtansine in patients who have platinum-resistant ovarian cancer with high folate receptor–alpha expression. Based on the results, Dr. Matulonis believes this agent might become a practice-changing, biomarker-driven standard-of-care treatment option (Abstract LBA4).

Advertisement

Advertisement




Advertisement